Advertisement

Approach to Depression in the Medically Ill

  • Kyung Bong Koh
Chapter

Abstract

It is desirable to evaluate patients’ medical and psychiatric status at the same time and consider multidimensional approaches in order to make a diagnosis of depression in the medically ill. Sometimes psychological instruments can be used to assess depression. For treatment, first, it is important to get rid of organic factors than any other things. Second, therapists should address patients’ resistance to psychiatric approaches and despondency response to severe physical diseases. Third, it is important to choose appropriate antidepressants as biological treatment. The selection of antidepressants in the medically ill should be considered after evaluating patients’ primary depressive symptoms, drug kinetics and dynamics, and side effects of antidepressants. Therapists also need to pay attention to drug-disease and drug-drug interactions. Antidepressants such as SSRIs, bupropion, and venlafaxine are effective for depression in the medically ill. However, tricyclic antidepressants can still be used effectively for patients with pain. In addition, collaborative care interventions are found to be effective in medically ill patients with depression. Therefore, clinicians’ therapeutic approach should be tailored to the specific needs of such patients in terms of biopsychosociospiritual perspectives.

Keywords

Multidimensional approaches Depression in the medically ill Despondency response Selection of antidepressants Drug-disease interactions Drug-drug interactions Collaborative care interventions 

References

  1. 1.
    Ban KH, Yum TH, Han HM. Report on depression assessed by Beck Depression Inventory in medical patients. J Korean Neuropsychiatr Assoc. 1987;26:464–73.Google Scholar
  2. 2.
    Oh BH, Cho DY, Kim NK. A study on anxiety and depression in cancer and non-cancer patients. J Korean Neuropsychiatr Assoc. 1986;25:121–31.Google Scholar
  3. 3.
    Lee SD, Cho SH, Kwak DI. The extent of depression and anxiety in medical inpatients. J Korean Neuropsychiatr Assoc. 1990;29:353–67.Google Scholar
  4. 4.
    Lee HS, Hong CH, Byun WT. A study on anxiety and depression in patients admitted at a general hospital. J Korean Neuropsychiatr Assoc. 1989;28:258–67.Google Scholar
  5. 5.
    Ha HK. A study on anxiety and depression in cancer patients. J Korean Neuropsychiatr Assoc. 1982;21:665–74.Google Scholar
  6. 6.
    Yang CK, Han HM. A study on patterns of depression symptoms in medical inpatients. J Korean Neuropsychiatr Assoc. 1995;34:379–90.Google Scholar
  7. 7.
    Yun SJ, Yang CK, Han HM. A study on depression, anxiety and sleep disturbance in patients on hemodialysis. J Korean Neuropsychiatr Assoc. 1999;38:997–1005.Google Scholar
  8. 8.
    Bukberg J, Penman D, Holland JC. Depression in hospitalized cancer patients. Psychosom Med. 1984;46:199–212.PubMedGoogle Scholar
  9. 9.
    Grassi L, Rosti G, Albieri G, et al. Depression and abnormal illness behavior in cancer patients. Gen Hosp Psychiatry. 1989;11:404–11.PubMedGoogle Scholar
  10. 10.
    Hinrichen GA, Lieberman JA, Pollack S, et al. Depression in hemodialysis patients. Psychosom Med. 1989;30:284–9.Google Scholar
  11. 11.
    Popkin MK, Callies AL, Mackenzie TB. The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry. 1985;42:1160–3.PubMedGoogle Scholar
  12. 12.
    Rodin G, Voshart K. Depression in the medically ill: an overview. Am J Psychiatry. 1986;143:696–705.PubMedGoogle Scholar
  13. 13.
    Yang L, Zuo C, Su L, Eaton MT. Depression in Chinese medical inpatients. Am J Psychiatry. 1987;144:226–8.PubMedGoogle Scholar
  14. 14.
    Rodin GM. Renal dialysis and the liaison psychiatrist. Can J Psychiatr. 1980;25:473–7.Google Scholar
  15. 15.
    Koh KB, Min SH, Min SK. The changing patterns of psychiatric consultations in a ten-year period. J Korean Neuropsychiatr Assoc. 1988;27:23–30.Google Scholar
  16. 16.
    Shevitz SA, Silberfarb PM, Lipowski ZJ. Psychiatric consultations in a general hospital—a report on 1,000 referrals. Dis Nerv Syst. 1976;37:295–300.PubMedGoogle Scholar
  17. 17.
    Lipowski ZJ, Wolston EJ. Liaison psychiatry: referral patterns and their stability over time. Am J Psychiatry. 1981;138:1608–11.PubMedGoogle Scholar
  18. 18.
    Bustamente JP, Ford CV. Characteristics of general hospital patients referred for psychiatric consultation. J Clin Psychiatry. 1983;42:338–41.Google Scholar
  19. 19.
    Katon W. Depression: relationship to somatization and chronic medical illness. J Clin Psychiatry. 1984;45:4–11.PubMedGoogle Scholar
  20. 20.
    Katon W, Roy-Byrne PP. Antidepressants in the medically ill: diagnosis & treatment in primary care. Clin Chem. 1988;34:829–36.PubMedGoogle Scholar
  21. 21.
    Kim KI. A symptomatological study on depression: 2. Patterns of depression symptoms in Koreans. J Korean Neuropsychiatr Assoc. 1977;16:46–52.Google Scholar
  22. 22.
    Nielsen AC, Williams TA. Depression in ambulatory medical patients. Arch Gen Psychiatry. 1980;37:999–1004.PubMedGoogle Scholar
  23. 23.
    Wilson I. Depression in the patient with COPD. Int J Chron Obstruct Pulmon Dis. 2006;1:61–4.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167:60–7.PubMedGoogle Scholar
  25. 25.
    Duric V, Clayton S, Leong ML, et al. Comorbidity factors and brain mechanisms linking chronic stress and systemic illness. Neural Plast. 2016;5460732.  https://doi.org/10.1155/2016/5460732. Epub 8 Feb 2016.Google Scholar
  26. 26.
    Regier DA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264:2511–8.PubMedGoogle Scholar
  27. 27.
    Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry. 1990;51(Suppl 6):3–11.PubMedGoogle Scholar
  28. 28.
    Rovner BW, German PS, Brant LJ. Depression and mortality in nursing homes. JAMA. 1991;265:993–6.PubMedGoogle Scholar
  29. 29.
    Simon GE, Vonkorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995;52:850–6.PubMedGoogle Scholar
  30. 30.
    Hall RCW. Depression in psychiatric presentations of medical illness: somatopsychic disorders. New York: SP Medical & Scientific Books; 1980.Google Scholar
  31. 31.
    Lewis KS. Emotional adjustment to a chronic illness. Lippincotts Prim Care Pract. 1998;2:38–51.PubMedGoogle Scholar
  32. 32.
    Freud S. Mourning and melancholia. In: Jones E, editor. Collected papers, vol. 4. 1950. London: Hogarth Press; 1917.Google Scholar
  33. 33.
    Spitz R. Anaclitic depression: an inquiry into the genesis of psychiatric conditions in early childhood. Psychoanal Study Child. 1942;2:313–42.Google Scholar
  34. 34.
    Bibring E. The mechanism of depression. In: Greenacre P, editor. Affective disorders. New York: International Universities Press; 1965.Google Scholar
  35. 35.
    Kohut H. The restoration of the self. New York: International Universities Press; 1977.Google Scholar
  36. 36.
    Cohen F, Lazarus RS. Coping with the stresses of illness. In: Stone GC, Cohen F, Adler NE, editors. Health psychology. San Francisco: Jossey-Bass; 1979.Google Scholar
  37. 37.
    Lin N, Dean A. Social support and depression: a panel study. Soc Psychiatry. 1984;9:83–91.Google Scholar
  38. 38.
    Akiskal HS, McKinney WT. Overview of recent research in depression. Arch Gen Psychiatry. 1975;32:285–305.PubMedGoogle Scholar
  39. 39.
    Cohen-Cole SA, Brown FW, McDaniel JS. Assessment of depression and grief reactions in the medically ill. In: Stoudemire A, Fogel BS, editors. Psychiatric care of the medical patient. New York: Oxford University Press; 1993.Google Scholar
  40. 40.
    Cunningham LA. Depression in the medically ill: choosing an antidepressant. J Clin Psychiatry. 1994;55(Suppl AJ):90–7.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Schulberg HC, Saul M, McClelland M. Assessing depression in primary medical and psychiatric practices. Arch Gen Psychiatry. 1985;42:1164–70.PubMedGoogle Scholar
  42. 42.
    Maguire P. The recognition and treatment of affective disorder in cancer patients. Int Rev Appl Psychol. 1984;33:479–91.Google Scholar
  43. 43.
    Keller M, Klerman G, Lavori P. Treatment received by depressed patients. JAMA. 1982;248:1848–55.PubMedGoogle Scholar
  44. 44.
    Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Arch Gen Psychiatry. 1978;35:773–82.PubMedGoogle Scholar
  45. 45.
    Clark DC, Cavanaugh SV, Gibbons RD. The core symptoms of depression in medical and psychiatric patients. J Nerv Ment Dis. 1983;171:705–13.PubMedGoogle Scholar
  46. 46.
    Hirschfeld RMA, Koslow SH, Kupfer DJ. The clinical utility of the dexamethasone suppression test in psychiatry. J Am Med Ass. 1983;250:2172.Google Scholar
  47. 47.
    Akiskal HS, Djenderedjian AH, Bolinger JM. The joint use of clinical and biological criteria for psychiatric diagnosis. In: Akiskal HS, Webb WL, editors. Psychiatric diagnosis: exploration of biological predictors. New York: Spectrum Publications; 1978.Google Scholar
  48. 48.
    Cavanaugh S. Depression in the medically ill. In: Judd FK, Burrows GD, Lipsitt DR, editors. Handbook of studies on general hospital psychiatry. Amsterdam: Elsevier Science Publishers BV (Biomedical Division); 1991.Google Scholar
  49. 49.
    Cavanaugh S, Clark D, Gibbons R. Diagnosing depression in the hospitalized medically ill. Psychosomatics. 1983;24:809–15.PubMedGoogle Scholar
  50. 50.
    Cavanaugh S. Depression in the medically ill: critical issues in diagnostic assessment. Psychosomatics. 1995;36:48–59.Google Scholar
  51. 51.
    Kathol RG, Mutgi A, Williams J. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry. 1990;147:1021–4.PubMedGoogle Scholar
  52. 52.
    Yang CK, Woo CH, Han HM. A study on depression in medical inpatients. J Korean Neuropsychiatr Assoc. 1992;31:1073–83.Google Scholar
  53. 53.
    Orive M, Padierna JA, Quintana JM, et al. Detecting depression in medically ill patients: comparative accuracy of four screening questionnaires and physicians’ diagnoses in Spanish population. J Psychosom Res. 2010;69:399–406.PubMedGoogle Scholar
  54. 54.
    Stoudemire A. Selected organic brain syndromes. In: Hales R, Yudofski, editors. Textbook of neuropsychiatry. Washington, DC: APA Press; 1987.Google Scholar
  55. 55.
    Cohen-Cole SA, Harpe C. Diagnostic assessment of depression in the medically ill. In: Stoudemire A, Fogel BS, editors. Principles of medical psychiatry. Orlando: Grune & Stratton; 1987.Google Scholar
  56. 56.
    Massie MJ, Holland JC. Diagnosis and treatment of depression in the cancer patient. J Clin Psychiatry. 1984;45:25–8.PubMedGoogle Scholar
  57. 57.
    Koh KB. An effective approach to somatization assessment and management. In: Koh KB, editor. Somatization and psychosomatic symptoms. New York: Springer; 2013. p. 99–111.Google Scholar
  58. 58.
    Bibring E. The mechanism of depression. In: Greenacre P, editor. Affective disorders: psychoanalytic contributions to their study. New York: International Universities Press; 1953.Google Scholar
  59. 59.
    Cassem NH. Depression. In: Cassem NH, editor. MGH handbook of general hospital psychiatry. 3d ed. Baltimore: Mosby Year Book; 1991.Google Scholar
  60. 60.
    Cassem NH, Hackett TP. Psychiatric consultation in a coronary care unit. Ann Intern Med. 1971;75:9–14.Google Scholar
  61. 61.
    Wishnie HA, Hackett TP, Cassem NH. Psychologic hazards of convalescence following myocardial infarction. JAMA. 1971;215:1292–6.PubMedGoogle Scholar
  62. 62.
    Unger KM, Moser KM, Hanser P. Selection of an exercise program for patients with chronic obstructive pulmonary disease. Heart Lung. 1980;9:68–76.PubMedGoogle Scholar
  63. 63.
    Pardy RL, Rivington RN, Despas PJ. Inspiratory muscle training compared with physiotherapy in patients with chronic airflow limitation. Am Rev Respir Dis. 1981;123:421–5.PubMedGoogle Scholar
  64. 64.
    Gift AG, Plaut SM, Jacox A. Psychologic and physiologic factors related to dyspnea in subjects with chronic obstructive pulmonary disease. Heart Lung. 1986;15:595–602.PubMedGoogle Scholar
  65. 65.
    Andrews JL Jr. Pulmonary rehabilitation. Pract Cardiol. 1986;12:127–37.Google Scholar
  66. 66.
    Glassman AH, Roose SP, Bigger JT. The safety of tricyclic antidepressants in cardiac patients [letter]. JAMA. 1993;269:2673–5.PubMedGoogle Scholar
  67. 67.
    Janowsky D, Curtis G, Zisook S. Ventricular arrhythmias possibly aggravated by trazodone. Am J Psychiatry. 1983;140:796–7.PubMedGoogle Scholar
  68. 68.
    Crewe HK, Lennard MS, Tucker GT. The effect of paroxetine and other specific serotonin reuptake inhibitors on cytochrome P450IID6 activity in human liver microsomes. Br J Clin Pharmacol. 1991;32:658–9.Google Scholar
  69. 69.
    Preskorn SH. Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry. 1993;54(Suppl 9):14–34.PubMedGoogle Scholar
  70. 70.
    Beliles K, Stoudemire A. Psychopharmacologic treatment of depression in the medically ill. Psychosomatics. 1998;39:S2–S19.PubMedGoogle Scholar
  71. 71.
    Hardy SE. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother. 2009;7:34–59.PubMedPubMedCentralGoogle Scholar
  72. 72.
    Levy NB. Chronic renal failure and its treatment: dialysis and transplantation. In: Stoudemire A, Fogel BS, editors. Psychiatric care of the medical patient. New York: Oxford University Press; 1993.Google Scholar
  73. 73.
    Beliles KE, Stoudemire A. Psychopharmacokinetics: clinical applications in medical illnesses. In: Stoudemire A, Fogel BS, editors. Medical psychiatric practice, vol. 3. Washington, DC: American Psychiatric Press Inc; 1995.Google Scholar
  74. 74.
    Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci. 1994;39:2352–63.PubMedGoogle Scholar
  75. 75.
    Gambertoglio JG. Effects of renal disease-altered pharmacokinetics. In: Benet LZ, Massoud N, Gambertoglio JG, editors. Pharmacokinetic basis for drug treatment. New York: Raven; 1984.Google Scholar
  76. 76.
    Levy NB. Psychopharmacology in patients with renal failure. Int J Psychiatry Med. 1990;20:325–34.PubMedGoogle Scholar
  77. 77.
    Brater DC, Vasko MR. Pharmacokinetics. In: Chernow B, Lake CR, editors. The pharmacologic approach to the critically ill patient. 2nd ed. Baltimore: Williams & Wilkins; 1988.Google Scholar
  78. 78.
    Bergstrom RF, Beasley CM, Levy NB. The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine. Int Clin Psychopharmacol. 1993;8:261–6.PubMedGoogle Scholar
  79. 79.
    Aronoff GR, Bergstrom RF, Pottratz ST. Fluoxetine kinetics and protein binding in normal and impaired renal function. Clin Pharmacol Ther. 1984;36:138–44.PubMedGoogle Scholar
  80. 80.
    Stoudemire A, Fogel BS. Psychopharmacology in medical patients: an update. In: Stoudemire A, Fogel BS, editors. Medical-psychiatric practice, vol. 3. Washington, DC: American Psychiatric Press; 1995.Google Scholar
  81. 81.
    Hedayati SS, Gregg LP, Carmody T, et al. Effect of sertraline on depressive symptoms in patients with chronic kidney disease without dialysis dependence: the CAST randomized clinical trial. JAMA. 2017;318:1876–90.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Holm E, Uhl W, Stamm S. Safety of fluvoxamine for patients with chronic liver disease: biochemical variables, psychometric performance and EEG. Adv Pharm. 1986;2:151–65.Google Scholar
  83. 83.
    Dalhoff K, Almdal TP, Bjerrum K. Pharmacokinetics of paroxetine in patients with cirrhosis. Eur J Clin Pharmacol. 1991;41:351–4.PubMedGoogle Scholar
  84. 84.
    Dechant KL, Clissold SP. Paroxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs. 1991;41:225–3.PubMedGoogle Scholar
  85. 85.
    van Harten J, Duchier J, Devissaguet J. Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration. Clin Pharmacokinet. 1993;24:177–82.PubMedGoogle Scholar
  86. 86.
    Pocha C, Knott A, Rector TS, et al. Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C? J Clin Psychiatry. 2014;75:e1122–6.PubMedGoogle Scholar
  87. 87.
    Thompson WL, Thompson TL II. Treating depression in asthmatic patients. Psychosomatics. 1984;25:809–12.PubMedGoogle Scholar
  88. 88.
    Reite M, Harbeck R, Hoffman A. Altered cellular immune response following peer separation. Life Sci. 1981;29:1133–6.PubMedGoogle Scholar
  89. 89.
    Thompson WL, Thompson TL II. Pulmonary disease. In: Stoudemire A, Fogel BS, editors. Principles of medical psychiatry. New York: Grune & Stratton; 1987.Google Scholar
  90. 90.
    Levitan H. Suicidal trends in patients with asthma and hypertension: a chart study. Psychother Psychosom. 1983;39:165–70.PubMedGoogle Scholar
  91. 91.
    Brown ES, Vigil L, Khan DA, Liggin JD, et al. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. Biol Psychiatry. 2005;58:865–70.PubMedGoogle Scholar
  92. 92.
    Thompson WL, Thompson TL II. Use of medications in patients with chronic respiratory disease. Adv Psychosom Med. 1985;14:136–48.PubMedGoogle Scholar
  93. 93.
    Brown ES, Howard C, Khan DA, et al. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study. Psychosomatics. 2012;53:75–80.PubMedGoogle Scholar
  94. 94.
    Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31:483–92.PubMedPubMedCentralGoogle Scholar
  95. 95.
    Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD – a review. Respir Med. 2011;105:1422–33.PubMedGoogle Scholar
  96. 96.
    McElroy SL, Keck PE, Friedman LM. Minimizing and managing antidepressant side-effects. J Clin Psychiatry. 1995;56(Suppl 2):49–55.PubMedGoogle Scholar
  97. 97.
    Nelson JC. Safety and tolerability of the new antidepressants. J Clin Psychiatry. 1997;58(Suppl 6):26–31.PubMedGoogle Scholar
  98. 98.
    Settle EC Jr. Antidepressant side effects: issues and options. J Clin Psychiatry. 1992;10:48–61.Google Scholar
  99. 99.
    Teicher MH, Cohen BM, Baldessarini RJ. Severe daytime somnolence in patients treated with an MAOI. Am J Psychiatry. 1988;145:1552–6.PubMedGoogle Scholar
  100. 100.
    Kunik ME, Veazey C, Cully JA, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med. 2008;38:3853–96.Google Scholar
  101. 101.
    Smith SM, Sonego S, Ketcheson L, et al. A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res. 2014;e000042:1.Google Scholar
  102. 102.
    Sirey JA, Raue PJ, Alexopoulos GS. An intervention to improve depression care in older adults with COPD. Int J Geriatr Psychiatry. 2007;22:154–9.PubMedPubMedCentralGoogle Scholar
  103. 103.
    Kuyken W, Warren FC, Taylor RS, et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiat. 2016;73:565–74.Google Scholar
  104. 104.
    Bohlmeijer E, Prenger R, Taal E, et al. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res. 2010;68:539–44.PubMedGoogle Scholar
  105. 105.
    Baumeister H, Hutter N. Collaborative care for depression in medically ill patients. Curr Opin Psychiatry. 2012;25:405–14.PubMedGoogle Scholar
  106. 106.
    Coventry PA, Bower P, Keyworth C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One. 2013;e60532:8.Google Scholar
  107. 107.
    Rackley S, Bostwick JM. Depression in medically ill patients. Psychiatr Clin North Am. 2012;35:231–47.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Kyung Bong Koh
    • 1
  1. 1.Department of PsychiatryYonsei University College of MedicineSeoulKorea

Personalised recommendations